Weight Loss
Reviewed by WeighedHealth Editorial Team · Last reviewed July 2026
Weight Loss programs,
compared.
Compare leading GLP-1 telehealth programs, Wegovy, Ozempic alternatives, and personalized weight loss plans.
Get personalized
in 60 seconds
Answer 8-10 questions about your goals, we'll match you with 3 programs.
Top weight loss programs
- #1WeightWatchers Clinic
WeightWatchers Clinic (formerly Sequence) — GLP-1 + WW coaching
"Now part of WeightWatchers, this is the most insurance-friendly option in the category."
- Insurance-covered GLP-1 (when eligible)
- From $99/mo (excl. medication)
- WW behavioral program included
- #2Hims
Hims Weight Loss — compounded GLP-1 from $199/mo
"Hims' weight-loss product is broader than just GLP-1 — they bundle coaching, meal planning, and behavioral content into a single subscription."
- Compounded semaglutide from $199/mo
- 100% online provider visits
- Free shipping, cancel anytime
- #3Henry Meds
Henry Meds — flat-rate compounded GLP-1, no hidden fees
"The price-leader for compounded GLP-1."
- Tirzepatide from $297/mo, semaglutide from $247/mo
- Compounded, no insurance
- Provider included in price
- #4Ro
Ro Body — branded GLP-1 weight care program
"The most polished GLP-1 program of the cohort."
- Compounded GLP-1 from $145/mo
- Licensed US provider consultation
- Free shipping, no insurance needed
- #5Noom Med
Noom Med — GLP-1 + behavioral psychology coaching
"Noom's psychology-first approach distinguishes it from pharma-led competitors."
- Tirzepatide & semaglutide from $179/mo
- Daily psychology-based coaching
- App + provider in one plan
- #6Found
Found — personalized weight loss, GLP-1 + other meds
"Found is the most flexible — they don't push GLP-1 by default."
- From $99/mo for membership (med priced separately)
- Insurance + cash-pay options
- Doctor + coach + dietitian
Not sure which is right for you?
60 seconds. We'll match you with the best 3 weight loss programs based on your specific situation.
Project your trial-average outcome
Move the slider to your current weight. The numbers below are trial-average results. Individual outcomes vary widely.
- Tirzepatide (Zepbound, 15 mg)−46 lbs
20.9% mean body-weight reduction at 72 weeks (SURMOUNT-1)
- Semaglutide (Wegovy, 2.4 mg)−33 lbs
14.9% mean body-weight reduction at 68 weeks (STEP-1)
- Placebo + lifestyle alone−5 lbs
2.4% mean body-weight reduction (STEP-1 placebo arm)
Trial averages, not predictions. Real-world outcomes depend on adherence, dose tolerance, diet, exercise, and individual response. ~10% of trial participants did not lose ≥5% body weight; ~30% achieved ≥20%.
Match me to a program →Will I qualify for a GLP-1?
FDA labels require BMI ≥30, or ≥27 with a weight-related condition. Check in two steps. This is an estimate, not a diagnosis.
Estimated BMI: 32.3
Educational estimate only. Eligibility is determined by a licensed clinician, not this tool.
Estimate your monthly GLP-1 cost
Pick your coverage situation. We'll show the realistic access paths and route you to the cheapest fit. Estimates, not quotes.
Estimates based on published 2026 pricing. Your actual cost depends on plan, dose, and pharmacy. Confirm before enrolling.
Availability by state
Number of partner programs prescribing in each state.
Northeast
Midwest
South
What we're watching
Upcoming events that could change the picture in this category.
FDA rule to permanently end mass compounding of semaglutide & tirzepatide
Comment period closes June 29, 2026; final rule expected H2 2026On April 30, 2026 the FDA proposed removing semaglutide, tirzepatide, and liraglutide from the 503B bulk-compounding list and issued 30 warning letters. If finalized, the cheap compounded-GLP-1 era ends and patients shift to branded or direct-channel pricing. Single biggest cost driver to watch in this category.
Source ↗Orforglipron launch via LillyDirect (oral non-peptide GLP-1)
PDUFA April 10, 2026; rollout through 2026Lilly's once-daily oral pill launches at $149/month via LillyDirect. Brand-only, no compounded versions. First oral non-peptide GLP-1 — expands the market to needle-averse patients and resets the price floor for branded GLP-1.
Source ↗Oral Wegovy (semaglutide 25 mg tablets) full commercial launch
Q3 2026Novo Nordisk filed oral semaglutide 25 mg for weight loss with the FDA (OASIS program). Its approval and distribution ramp will determine whether oral becomes a real alternative to injection.
Source ↗Generic liraglutide (Saxenda) availability
Late 2026 — early 2027Saxenda patents expire 2024-2025. Generic liraglutide could undercut Saxenda by 60-80% if multiple manufacturers enter.
Orforglipron Phase 3 readout (oral non-peptide GLP-1)
Late 2026Lilly's once-daily oral pill could expand the market to people who refuse injections. Different chemistry from semaglutide — no peptide degradation.
Source ↗Medicare Part D weight-loss coverage decision
Watching CMS announcements through 2026Current law bars Medicare from covering weight-loss drugs. Pending legislative changes could open coverage for ~13M seniors with obesity.
Frequently asked
What's the difference between Wegovy, Ozempic, and Zepbound?+
Wegovy and Ozempic both contain semaglutide; Wegovy is FDA-approved for weight loss, Ozempic for type-2 diabetes (off-label for weight loss). Zepbound contains tirzepatide (dual GIP/GLP-1 agonist), FDA-approved for weight loss with typically larger average weight reductions (~22% vs ~15% in head-to-head dosing). All are weekly injections.
How much weight can I expect to lose on a GLP-1?+
STEP-1 trial showed ~15% average body-weight reduction with semaglutide 2.4mg at 68 weeks. SURMOUNT-1 trial showed ~22% with tirzepatide 15mg at 72 weeks. Real-world adherence is lower than trial conditions — most patients see 8-15% loss depending on dose tolerated and lifestyle integration.
What happens if I stop taking a GLP-1?+
Most patients regain 50-80% of lost weight within 1-2 years of stopping. This is consistent across all anti-obesity medications, not unique to GLP-1s. Many clinicians frame GLP-1 therapy as long-term chronic disease management similar to BP or thyroid meds.
Are compounded GLP-1s safe and legal?+
Compounded semaglutide and tirzepatide were prescribed during 2023-2024 FDA-declared shortages under 503A/503B compounding rules. As of 2025-2026, FDA has removed both from the shortage list, narrowing legal compounding to specific patient-need cases (allergies, dose adjustments not commercially available). Verify the compounding pharmacy holds proper licensing in your state.
How do I choose between weight loss programs?+
Compare on five things: clinical model (who's prescribing and their credentials), full out-of-pocket pricing (not just headline price), what's included (medication, coaching, follow-up), cancellation terms, and state availability. Our assessment surfaces the program most aligned with these factors based on your answers.
Are these programs covered by insurance?+
It depends on the program. Some weight loss services are in-network with major insurers (especially mental health, BP, cholesterol). Others are cash-pay only (most compounded GLP-1 and on-demand ED). Use the assessment to filter for insurance-friendly options.
Is online care as good as in-person care?+
For many chronic conditions, online care is clinically equivalent and often more accessible, the FDA and major medical bodies now recognize telehealth as a valid model. However, in-person evaluation is still required for some procedures and emergencies. The partner programs we compare all use licensed US providers.
Will my employer or insurance see this?+
If you pay cash, no, there's no claim filed. If you use insurance, the partner brand bills under standard CPT codes, which may appear on your explanation of benefits. Each partner discloses their billing approach during intake.
What happens if a program isn't working?+
Every partner we list lets you cancel at any time. Most also offer a money-back guarantee or first-month refund if results don't meet expectations. We surface cancellation policies in each program's review.